| Quantifiable predictive features define epitope-specific T cell receptor repertoires P Dash, AJ Fiore-Gartland, T Hertz, GC Wang, S Sharma, A Souquette, ... Nature 547 (7661), 89-93, 2017 | 989 | 2017 |
| The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1 PG Thomas, P Dash, JR Aldridge, AH Ellebedy, C Reynolds, AJ Funk, ... Immunity 30 (4), 566-575, 2009 | 891 | 2009 |
| De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation HE Ghoneim, Y Fan, A Moustaki, HA Abdelsamed, P Dash, P Dogra, ... Cell 170 (1), 142-157. e19, 2017 | 834 | 2017 |
| TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection JR Aldridge Jr, CE Moseley, DA Boltz, NJ Negovetich, C Reynolds, ... Proceedings of the National Academy of Sciences 106 (13), 5306-5311, 2009 | 779 | 2009 |
| VDJdb: a curated database of T-cell receptor sequences with known antigen specificity M Shugay, DV Bagaev, IV Zvyagin, RM Vroomans, JC Crawford, G Dolton, ... Nucleic acids research 46 (D1), D419-D427, 2018 | 644 | 2018 |
| Influenza virus-related critical illness: pathophysiology and epidemiology AC Kalil, PG Thomas Critical care 23 (1), 258, 2019 | 634 | 2019 |
| Cell-mediated protection in influenza infection PG Thomas, R Keating, DJ Hulse-Post, PC Doherty Emerging infectious diseases 12 (1), 48, 2006 | 615 | 2006 |
| Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand QS Huang, T Wood, L Jelley, T Jennings, S Jefferies, K Daniells, ... Nature communications 12 (1), 1001, 2021 | 541 | 2021 |
| Influenza virus Z-RNAs induce ZBP1-mediated necroptosis T Zhang, C Yin, DF Boyd, G Quarato, JP Ingram, M Shubina, KB Ragan, ... Cell 180 (6), 1115-1129. e13, 2020 | 528 | 2020 |
| Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections HE Ghoneim, PG Thomas, JA McCullers The Journal of Immunology 191 (3), 1250-1259, 2013 | 494 | 2013 |
| Cytomegalovirus infection enhances the immune response to influenza D Furman, V Jojic, S Sharma, SS Shen-Orr, CJ L. Angel, ... Science translational medicine 7 (281), 281ra43-281ra43, 2015 | 491 | 2015 |
| Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination AH Ellebedy, KJL Jackson, HT Kissick, HI Nakaya, CW Davis, KM Roskin, ... Nature immunology 17 (10), 1226-1234, 2016 | 469 | 2016 |
| DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death RJ Thapa, JP Ingram, KB Ragan, S Nogusa, DF Boyd, AA Benitez, ... Cell host & microbe 20 (5), 674-681, 2016 | 466 | 2016 |
| Influenza and the challenge for immunology PC Doherty, SJ Turner, RG Webby, PG Thomas Nature immunology 7 (5), 449-455, 2006 | 460 | 2006 |
| Receptor interacting protein kinase 2–mediated mitophagy regulates inflammasome activation during virus infection C Lupfer, PG Thomas, PK Anand, P Vogel, S Milasta, J Martinez, G Huang, ... Nature immunology 14 (5), 480-488, 2013 | 443 | 2013 |
| Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract T Flerlage, DF Boyd, V Meliopoulos, PG Thomas, S Schultz-Cherry Nature Reviews Microbiology 19 (7), 425-441, 2021 | 437 | 2021 |
| Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism PG Thomas, MR Carter, O Atochina, AA Da’Dara, D Piskorska, E McGuire, ... The Journal of Immunology 171 (11), 5837-5841, 2003 | 413 | 2003 |
| RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus S Nogusa, RJ Thapa, CP Dillon, S Liedmann, TH Oguin, JP Ingram, ... Cell host & microbe 20 (1), 13-24, 2016 | 412 | 2016 |
| ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis T Zhang, C Yin, A Fedorov, L Qiao, H Bao, N Beknazarov, S Wang, ... Nature 606 (7914), 594-602, 2022 | 361 | 2022 |
| New fronts emerge in the influenza cytokine storm XJ Guo, PG Thomas Seminars in immunopathology 39 (5), 541-550, 2017 | 344 | 2017 |
Jeremy Chase CrawfordSt. Jude Children's Research HospitalVerified email at stjude.org
